It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Implantation of biological corneal inlays, derived from small incision lenticule extraction, may be a feasible method for surgical management of refractive and corneal diseases. However, the refractive outcome is dependent on stromal remodelling of both the inlay and recipient stroma. This study aimed to investigate the refractive changes and tissue responses following implantation of 2.5-mm biological inlays with or without corneal collagen crosslinking (CXL) in a rabbit model. Prior to implantation, rotational rheometry demonstrated an almost two-fold increase in corneal stiffness after CXL. After implantation, haze gradually subsided in the CXL-treated inlays (p = 0.001), whereas the untreated inlays preserved their clarity (p = 0.75). In-vivo confocal microscopy revealed reduced keratocyte cell count at the interface of the CXL inlays at week 8. Following initial steepening, regression was observed in anterior mean curvature from week 1 to 12, being most prominent for the non-CXL subgroups (non-CXL: −12.3 ± 2.6D vs CXL: −2.3 ± 4.4D at 90 μm depth, p = 0.03; non-CXL: −12.4 ± 8.0D vs CXL: −5.0 ± 4.0D at 120 μm depth, p = 0.22). Immunohistochemical analysis revealed comparable tissue responses in CXL and untreated subgroups. Our findings suggest that CXL of biological inlays may reduce the time before refractive stabilization, but longer postoperative steroid treatment is necessary in order to reduce postoperative haze.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Aarhus University Hospital, Department of Ophthalmology, Aarhus, Denmark (GRID:grid.154185.c) (ISNI:0000 0004 0512 597X); Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670)
2 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Graduate Medical School, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
3 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Nanyang Technological University, School of Materials Science and Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361)
4 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670)
5 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
6 Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Nanyang Technological University, School of Materials Science and Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361); Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-NUS Graduate Medical School, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)